Helping projects
change the future
APPLY NOW

News

How passion for math and biology brought COO Primer Capital to the venture industry

9 January 2018

Elizaveta Rozhdestvenskaya told Firrma how she started in the venture business, whose life example inspires her and what her typical day looks like.

How passion for math and biology brought COO Primer Capital to the venture industry

Elizaveta Rozhdestvenskaya told Firrma how she started in the venture business, whose life example inspires her and what her typical day looks like.
 

FK Laboratoriz successfully completes pre-clinical development of a medication for treatment and prevention of thrombosis

26 December 2017

FK Laboratoriz, a project company in Primer Capital’s portfolio, has completed pre-clinical trials of a new original molecula under the contract with the Russian Ministry of Education and Science as part of Pharma-2020 Federal Target Program.

FK Laboratoriz successfully completes pre-clinical development of a medication for treatment and prevention of thrombosis

FK Laboratoriz, a project company in Primer Capital’s portfolio, has completed pre-clinical trials of a new original molecula under the contract with the Russian Ministry of Education and Science as part of Pharma-2020 Federal Target Program.
 

Seed Forum 2017

14 December 2017

This international investment forum takes place in 55 countries and unites thousands of funds and business angels all over the world.

Seed Forum 2017

This international investment forum takes place in 55 countries and unites thousands of funds and business angels all over the world.
 

Young Starts in Russian VC & PE

8 December 2017

Nadezhda Kartashova, a project manager in Primer Capital, was ranked second among finalists of the “Young Stars in Russian VC & PE” contest.

Young Starts in Russian VC & PE

Nadezhda Kartashova, a project manager in Primer Capital, was ranked second among finalists of the “Young Stars in Russian VC & PE” contest.
 

Venture Investments Course by the Skolkovo Moscow School of Management

5 December 2017

On December 3, 2017, I have attended the Venture Investments Course. During this event, I presented a speech about structuring of venture transactions and risk minimization methods for investors.

Venture Investments Course by the Skolkovo Moscow School of Management

On December 3, 2017, I have attended the Venture Investments Course. During this event, I presented a speech about structuring of venture transactions and risk minimization methods for investors.
 

Eurika! Concept

28 November 2017

Primer Capital was invited to join a panel of judges at the ‘New Approaches to Drug Development’ sub-section on November 23, 2017 as part of annual reporting session for winners of the ‘Eureka! Concept’ competition.

Eurika! Concept

Primer Capital was invited to join a panel of judges at the ‘New Approaches to Drug Development’ sub-section on November 23, 2017 as part of annual reporting session for winners of the ‘Eureka! Concept’ competition.
 

Biotech and Money

23 November 2017

Last week, we visited London for a conference organized by Biotech and Money community. 

Biotech and Money

Last week, we visited London for a conference organized by Biotech and Money community. 
 

BIO-Europe 2017

10 November 2017

At the BIO-Europe 2017, which took place in Berlin this year, Primer Capital was looking for new developments and partners for co-investment.

BIO-Europe 2017

At the BIO-Europe 2017, which took place in Berlin this year, Primer Capital was looking for new developments and partners for co-investment.
 

Russian start-ups are invited to join CoLaborator

9 November 2017

The CoLaborator has started the recruitment of biotech and pharmaceutical start-ups to join the project.

Russian start-ups are invited to join CoLaborator

The CoLaborator has started the recruitment of biotech and pharmaceutical start-ups to join the project.
 

Primer Capital and Bayer became partners to support biotech start-ups

23 October 2017

Primer Capital and pharmaceutical company Bayer signed an agreement to work together in the search for promising pharmaceutical and biomedical projects.

Primer Capital and Bayer became partners to support biotech start-ups

Primer Capital and pharmaceutical company Bayer signed an agreement to work together in the search for promising pharmaceutical and biomedical projects.

Записи 1 - 10 of 12
First | Prev. | 1 2 | Next | Last